As of 2024-12-13, the Fair Value of Reneo Pharmaceuticals Inc (RPHM) is -2.35 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.82 USD, the upside of Reneo Pharmaceuticals Inc is -229.31%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -19.47 | -39.77 | -51.96 | -77.39 | -47.15 | |
| YoY growth | -56.51% | -104.26% | -30.65% | -48.94% | -60.09% | |
| Market Cap (mil) | 218.63 |
| P/E | |
| Forward P/E |
| EPS | -0.47 |
| Avg earnings growth rate | -60.09% |
| TTM earnings | -56.54 |